BURLINGAME, Calif., April 1 /PRNewswire/ — Today, Collaborative Drug Discovery (CDD) brings Andrea Barry on board to spearhead an initiative to expand into the pharmaceuticals market, building on widespread acceptance of CDD’s platform among academic and biotech researchers.
Andrea Barry was the Director of North American Sales for SciTegic prior to its merger with Accelrys, Inc. Her team was responsible for 2/3 of the global revenue for the company.
“Andrea has proven herself to be a game-changer,” said Barry Bunin, CEO of CDD. “She brought significant growth to MDL, SciTegic and Accelrys – the powerhouses of traditional software tools in the commercial market – so we are confident that she will successfully translate our web-based collaborative approach to our growing number of large pharmaceutical customers.”
Bunin continues: “We’re as interested in Andrea’s ability to develop a community and to strengthen a revolutionary brand as in her skills as a revenue builder. We welcome her to the team and look forward to building new commercial relationships together.”
Andrea Barry commented, “It’s my privilege to join the CDD team at this exciting point in the company history. Great technology, a superior team of technical, scientific and business experts, and a culture that drives and thrives on collaboration: these are just a few of the important reasons I believe in CDD and where it’s headed.”
About the CDD platform (CDD Vault™, CDD Collaborate™, and CDD Public™):
The CDD platform contains a completely redesigned data import workflow with templates to streamline the data upload process. The rest of the site is organized more intuitively, with a separate section for each distinct major activity. Searching and browsing molecules and protocols are now performed in the “Explore Data” section of the application. The “Share Data” section makes collaboration (without sacrificing security) a breeze. The new Dashboard brings relevant information forward immediately upon login. Subsequent releases are planned on a regular basis incorporating feedback from the growing community. CDD supports alliances, crowd-sourcing, and custom applications.
About Collaborative Drug Discovery, Inc.:
CDD (www.collaborativedrug.com) provides the most widely used web-based drug discovery software platform on the market. “CDD Vault™” is the secure, private industrial-strength database combining traditional drug discovery informatics (registration and SAR) with social networking capabilities. “CDD Collaborate™” enables real-time collaboration by securely exchanging selected confidential data with external researchers. “CDD Public™” enables researchers to mine a unique aggregation of information from a variety of scientific data providers.
CONTACT: Barry Bunin, Ph.D., President & CEO of Collaborative Drug Discovery, Inc., +1-650-204-3084, email@example.com